News | June 09, 2026
FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Broadening access for children & patients with inhibitor-complicated hemophilia
We are building the bridge between complex molecular data and everyday clinical decisions
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
